Ledger.Open graph →
SEC Form D · Amendment · filed December 6, 2023

Sensorium Therapeutics, Inc

Offering
$24.8M
Sold
$24.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Richard Simon · New York, NYExec · DirectorPranav Tadi · Waltham, MAExecJerrold Rosenbaum · Waltham, MADirectorKevin Lalande · Austin, TXDirectorRyan Katz · Atlanta, GADirectorRichard Simon · Waltham, MAExec · DirectorPranav Tadi · Waltham, MAExecJerrold Rosenbaum · Waltham, MADirectorKevin Lalande · South San Francisco, CADirectorRyan Katz · Rockville, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗